News Center
Implementation of international cooperation! Bio-sincerity Pharma collaborates with Delim to build a new collaborative ecosystem
2026-02-05

1.png

Recently, Hangzhou Bio-sincerity Pharma-Tech Co., Ltd. (hereinafter abbreviated as "Bio-sincerity Pharma") officially signed a strategic cooperation agreement with Delim Cosmetics & Pharma S.R.L. (hereinafter abbreviated as "Delim"). Prior to the ceremony, both parties engaged in in-depth discussions regarding global pharmaceutical industry trends, key areas for collaboration, and the development paths for core products. Building on the integration of their core competencies and industrial resources, the two parties aim to bridge the critical chain from technology transfer and market access to industrialization, forging a deeply collaborative and mutually empowering partnership.

2.png

 

3.png

Multi-Dimensional Synergy and Integration

Create a Multi-Dimensional Cooperation System

 

Taking this strategic cooperation as a catalyst, Bio-sincerity Pharma is building a comprehensive and deep-level cooperation framework to maximize resource complementarity and capability synergy.

 

Serving as the exclusive industrialization partner for Delim in China, Bio-sincerity Pharma will utilize CDMO Pharma's premier production conversion capacity to fast-track the launch of European innovative achievements in the domestic market, benefiting global patients with high efficiency and superior quality.

 

Bio-sincerity Pharma is granted the priority of strategic cooperation on Delim’s marketed product.

 

Leveraging its long-standing R&D prowess, Bio-sincerity Pharma is committed to propelling more domestic breakthroughs onto the global market. Delim will play the dual role of bridge and catalyst, facilitating the transition of high-potential domestic products into Europe-compliant innovations and maximizing their value on a global scale.

 

Focus on Core Products

Unleashing New Momentum for Synergistic Value

 

This collaboration first targets high-value-added products, covering the R&D, manufacturing, and commercialization of innovative oral preparation for Semaglutide, Tirzepatide, and Minoxidil to unleash significant synergies.

Founded in 2008, Delim Cosmetics & Pharma S.R.L. is a specialized pharma company dedicated to the R&D of pharmaceuticals, cosmetics, and medical devices. With operations covering the entire lifecycle from formulation to regulatory registration, Delim also offers vital sales training and channel collaboration services to facilitate the successful entry and commercialization of pharmaceutical products across Europe.

 

 


You are welcome to contact us via the online form below.

We will answer your inquiries in various ways, and jointly provide customized professional consultation and solutions for your research and development needs.

What information and information do you want to know?
General consultation
General consultation
Media and investment
Content of your inquiry
name
email
telphone
address
code